Microglial Fructose Metabolism Is Essential for Glioblastoma Growth
Leah K. BillinghamiD, Susan L DeLay, Yasmina EshaciD, Tzu-Yi Chia, Shashwat TripathiiD, Ian E Olson, Kaylee ZilingeriD, Jay SubbiahiD, Zhaoquan WangiD, Nishanth S. SadagopaniD, Hinda NajemiD, Guillaume CognetiD, Joshua L. KatziD, Ruochen DuiD, Khizar Rehan NandoliyaiD, Lauren K. BolandiD, Gustavo Ignacio Vázquez CervantesiD, Si WangiD, Hanxiao Wan, Allie B. LipshutziD, Alina R MurphyiD, Joseph T. DuffyiD, I. V. BalyasnikovaiD, Peng ZhangiD, Dieter Henrik HeilandiD, , Jason M. MiskaiD
Abstract
Glioblastoma (GBM) is most common and aggressive primary brain tumor in adults, for which standard of care hasnt changed in twenty years. GBM tumor associated macrophages (TAMCs), consisting of infiltrating myeloid cells from the periphery and resident microglia cells, are pro-tumorigenic, promoting tumor growth. Fructose is one of the most abundant metabolites in the GBM tumor microenvironment (TME), as well as in the healthy central nervous system (CNS). In the CNS and GBM, microglia are the predominant expressors of the fructose transporter GLUT5. Mice lacking the GLUT5 transporter (GLUT5-KO) survive significantly longer after orthotopic implantation of two glioma cell lines than wildtype mice, which is not due to dietary fructose or peripherally derived TAMCs. Investigation of the TME showed that GLUT5-KO mice have more highly activated and inflammatory innate and adaptive immune compartments. Microglia cultured in fructose have a decreased phagocytic ability and exhibit decreased inflammatory capacity due to the polyol pathway promoting redox homeostasis.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 5
- FWCI
- 22.10
- Field percentile
- top 1%
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- FGFR1 inhibition prevents metabolic adaptation associated with therapy resistance in glioblastoma
Laura Zarzuela, Ignacio G. López-Cepero, … Raúl V. Durán·bioRxiv·Jan 11, 2025
- Glioblastoma utilizes fatty acids and ketone bodies for growth allowing progression during ketogenic diet therapy
J. Sperry, M. C. Condro, … H. I. Kornblum·bioRxiv·Aug 11, 2020
- Sweet taste receptor regulates proliferation and glucose uptake in glioblastoma cells
Ana Raquel Costa, Ana Catarina Duarte, … Cecília R.A. Santos·bioRxiv·Jun 27, 2025
- FAK inhibitor treatment systemically regulates the glioblastoma immune environment via blocking monocyte trafficking
Emily R. Webb, A. R. S. Black, … Valerie G. Brunton·bioRxiv·Nov 26, 2025
- FAK modulates glioblastoma stem cell energetics via regulation of glycolysis and glutamine oxidation
Roza H. Ali Masalmeh, John C. Dawson, … Margaret C. Frame·Disease Models & MechanismsPeer-reviewed·Sep 22, 2025
- Radiation Induced Metabolic Alterations Associate with Tumor Aggressiveness and Poor Outcome in Glioblastoma
K. Gupta, I. Vuckovic, … T. Burns·bioRxiv·Feb 4, 2020